Xencor, Inc.
ENGINEERED IL-2 Fc FUSION PROTEINS
Last updated:
Abstract:
The present invention provides IL-2-Fc fusion proteins comprising IL-2 variants.
Status:
Application
Type:
Utility
Filling date:
18 Jan 2022
Issue date:
7 Jul 2022